Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


Business Summary
Logo Immunocore Holdings plc
Immunocore Holdings plc, formerly Immunocore Holdings Ltd, is a late-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies called Immune mobilizing monoclonal TCRs Against X disease (ImmTAX) designed to treat diseases, including cancer, infectious and autoimmune. The Company is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. The CompanyÔÇÖs pipeline is leveraging ImmTAX platform within three therapeutic areas: oncology, infectious disease and autoimmune disease.
Sales per Business
Genentech24.3674.4%25.9567.2% +6.51%
GlaxoSmithKline7.3422.4%8.1521.1% +11.05%
Eli Lilly1.043.2%4.5211.7% +332.27%
USD in Million
Sales per region
United States25.4177.6%30.4778.9% +19.91%
United Kingdom7.3422.4%8.1521.1% +11.05%
USD in Million
Name Title Age Since
Bahija Jallal, Dr. Chief Executive Officer & Director 58 2019
Brian R. DiDonato Chief Financial Officer & Head-Strategy 53 2020
David Berman, Dr. Head-Research & Development - 2019
Roy Steven Herbst, Dr. Non-Executive Director 57 2021
Ralph Torbay Head-Commercial - 2021
Members of the board
Name Title Age Since
Bahija Jallal, Dr. Chief Executive Officer & Director 58 2019
John Irving Bell, Dr. Non-Executive Director 69 2015
Travis Coy Non-Executive Director - 2019
Robert J. Perez Non-Executive Director 56 2019
Kristine Peterson Non-Executive Director 60 2017
Roy Steven Herbst, Dr. Non-Executive Director 57 2021
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 44,617,715 32,762,844 73.4% 0 0.0% 73.4%
Baker Bros. Advisors LP 2,520,730 5.87%
Rock Springs Capital Management LP 2,445,155 5.69%
Fidelity Management & Research Co. LLC 1,750,074 4.07%
RTW Investments LP 1,245,532 2.90%
Avidity Partners Management LP 1,095,600 2.55%
Wellington Management Co. LLP 1,052,075 2.45%
General Atlantic LLC 950,000 2.21%
Bain Capital Public Equity LP 638,205 1.49%
Bill & Melinda Gates Foundation Trust (Investment Management) 576,923 1.34%
BlackRock Advisors LLC 572,791 1.33%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Immunocore Holdings plc
Sector Other Biotechnology & Medical Research